Agenus Inc. Completes $115M Non-Dilutive Royalty Transaction with Oberland Capital
September 09, 2015 at 07:02 AM EDT
Agenus Inc. (NASDAQ: AGEN), an immunology company discovering and developing innovative treatments for cancers and other diseases, today ...